
Dx Deals: Labcorp and BioReference Health Agree on $225m Sale of Some Assets
Labcorp will acquire oncology-related clinical tests services from BioReference’s parent company, OPKO Health
Labcorp will acquire oncology-related clinical tests services from BioReference’s parent company, OPKO Health
Quest Diagnostics will find out as it launches a new health coaching business that relies on lab testing, via its Pack Health subsidiary
The new rules, which were approved by the FTC in October and will go into effect in mid-January, aim to put a damper on consolidation
$152.1 million SYNLAB deal is expected to create a new channel for Labcorp to market its sophisticated specialty assays
The rounds of funding to Clarapath, PreciseDx, and Precision Epigenomics come at a time when other M&A activity is seasonally slow